The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Reiner Benecke sits on this spectrum.
This scientist: 347 publications — 87th percentile
87% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 887 publications or more.
The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Reiner Benecke sits on this spectrum.
This scientist: 87 D-Index — 87th percentile
87% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 163 D-Index or more.
Reiner Benecke is affiliated with the University of Rostock in Germany, focusing on research within the fields of Medicine and Neuroscience. Their work emphasizes neurological disorders and treatments, with particular attention to botulinum toxin and related neurological conditions as well as hereditary neurological disorders.
The scientist's recent publications include the paper titled Frequency and risk factors of antibody-induced secondary failure of botulinum neurotoxin therapy, published in 2020 in the journal Neurology. This publication explores important aspects of therapeutic responses in botulinum neurotoxin treatments and has been cited 46 times, indicating ongoing relevance in the research community.
Research collaborations have included frequent co-authors such as Uwe Walter, Christopher Mühlenhoff, Dirk Dressler, Eilhard Mix, and Janes Alt. These collaborators have contributed to advancing the understanding of neurological therapies and mechanisms.
Reiner Benecke's research has been published predominantly in the journal Neurology, which is also reflected in the focus on clinical neurology and related biomedical investigations.
The core subfields of Benecke's academic work include Neurology and Cellular and Molecular Neuroscience, highlighting a blend of clinical and basic science approaches in their research methodology.
The primary topics addressed in Benecke's research are:
This profile reflects a scientist concentrated on neurological mechanisms and therapeutic interventions, contributing to the broader knowledge of how treatments such as botulinum neurotoxin are influenced by immunological factors and genetic components.
Katja Stefan;Erwin Kunesch;Leonardo G. Cohen;Reiner Benecke
Andreas Kupsch;Reiner Benecke;Jörg Müller;Thomas Trottenberg
Konrad J. Werhahn;Erwin Kunesch;Soheyl Noachtar;Reiner Benecke
Katja Stefan;Erwin Kunesch;Reiner Benecke;Leonardo G. Cohen
Alexander Wolters;Friedhelm Sandbrink;Antje Schlottmann;Erwin Kunesch
R. Benecke;J. C. Rothwell;J. P. R. Dick;B. L. Day
Arndt Rolfs;Tobias Böttcher;Marlies Zschiesche;Peter Morris
R. Benecke;J. C. Rothwell;J. P. R. Dick;B. L. Day
H. Roick;H. J. von Giesen;R. Benecke
R. Benecke;B.-U. Meyer;H.-J Freund
A. M. O. Bakheit;A. F. Thilmann;A. B. Ward;W. Poewe
Jens Volkmann;Jens Volkmann;Alexander Wolters;Andreas Kupsch;Jörg Müller
Kirn R. Kessler;Michael Skutta;R. Benecke
P.D. Thompson;A. Berardelli;J.C. Rothwell;B.L. Day
J. P. R. Dick;J. C. Rothwell;B. L. Day;R. Cantello
Jens Volkmann;Joerg Mueller;Günther Deuschl;Andrea A. Kühn
F. Binkofski;R. J. Seitz;S. Arnold;J. Classen
R. Benecke;W. H. Jost;P. Kanovsky;E. Ruzicka
U. Walter;L. Niehaus;T. Probst;R. Benecke
Reiner Benecke;Petra Strümper;Hanns Weiss
If you think any of the details on this page are incorrect, let us know.
Argonne National Laboratory
Public Health Agency of Canada
Forschungszentrum Jülich
University of Oxford
Oregon State University
University of New South Wales
King's College London
University of Sheffield
Swinburne University of Technology
Monash University
Yamaguchi University
Michigan State University
Kozminski University
Duke University
Autonomous University of Barcelona
University of Hannover
